2025Proceedings of the National Academy of Sciences of the United States of America122 (28) : e2500276122

Mycophenolic acid treatment drives the emergence of novel SARS-CoV-2 variants

Meister T, Nocke M, Heinen N, Burkard T, Brüggemann Y, Westhoven S, Trüeb B, Ebert N, Thomann L, Lubieniecki K, Lubieniecka J, Döring K, Herrmann M, Haid S, Pietschmann T, Wiegmann B, Tao R, Pfefferle S, Addo M, Thiel V, Drexler I, Babel N, Phuc Nguyen H, Brown R, Todt D, Steinmann E, Pfaender S

2024Frontiers in Immunology15 : 1443665

A clinical protocol for a German birth cohort study of the Maturation of Immunity Against respiratory viral Infections (MIAI)

Hartmann C, Khan R, Schöning J, Richter M, Willers M, Pirr S, Heckmann J, Dirks J, Morbach H, Konrad M, Fries E, Winkler M, Büchel J, Seidenspinner S, Fischer J, Vollmuth C, Meinhardt M, Marissen J, Schmolke M, Haid S, Pietschmann T, Backes S, Dölken L, Löber U, Keil T, Heuschmann P, Wöckel A, Sagar, Ulas T, Forslund-Startceva S, Härtel C, Viemann D

2024Nature Communications15 (1) : 1173

Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor

Sake S, Zhang X, Rajak M, Urbanek-Quaing M, Carpentier A, Gunesch A, Grethe C, Matthaei A, Rückert J, Galloux M, Larcher T, Le Goffic R, Hontonnou F, Chatterjee A, Johnson K, Morwood K, Rox K, Elgaher W, Huang J, Wetzke M, Hansen G, Fischer N, Eléouët J, Rameix-Welti M, Hirsch A, Herold E, Empting M, Lauber C, Schulz T, Krey T, Haid S, Pietschmann T